我国男男性行为人群中人乳头瘤病毒疫苗接种的需求与建议  

Human papillomavirus vaccination for men who have sex with men in China:demand and suggestions

作　　者：刘昕[1] 张菱 荆舒 吴奕锦 苏小游[1] 乔友林[1] Liu Xin;Zhang Ling;Jing Shu;Wu Yijin;Su Xiaoyou;Qiao Youlin(School of Population Medicine and Public Health,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China)

机构地区：[1]中国医学科学院北京协和医学院群医学及公共卫生学院,北京100730

出　　处：《中华流行病学杂志》2023年第8期1321-1326,共6页Chinese Journal of Epidemiology

基　　金：比尔及梅琳达•盖茨基金会-中华预防医学会:人乳头状瘤病毒疫苗扩大免疫规划研究(2021P057QG006-2);北京市教育委员会群医学学科建设(2021-EFT-Z-009)。

摘　　要：MSM是HPV感染与相关疾病发生的高危人群,四价和九价HPV疫苗能够为MSM提供有效的保护。本文综述了为MSM提供HPV疫苗接种的重要性,综合了关于MSM接种HPV疫苗的依据并提出建议:我国应加快HPV疫苗在男性中使用的适应症研究及审批;尽快为HIV阳性的MSM接种HPV疫苗;优先为≤26岁MSM接种HPV疫苗;在HPV疫苗资源充分的情况下,为>26岁的MSM进行补接种或机会性接种。采用这种接种策略能够为MSM提供保护,控制性病和艾滋病的传播。MSM are a high-risk population for HPV infection and related diseases.MSM can be effectively protected by quadrivalent and nine-valent HPV vaccines.This paper outlines the significance of providing HPV vaccination to MSM,summarizes the basis of HPV vaccination in MSM,and puts forward the following recommendations.First,China should expedite the development and approval of the HPV vaccine for male use.Second,HIV-positive MSM should vaccinate against HPV as soon as possible.Third,prioritize HPV vaccination for MSM individuals aged 26 or less.Fourth,for MSM aged over 26,catch-up vaccination or opportunistic vaccination should be provided when HPV vaccine resources are sufficient.Implementing this vaccination strategy can provide protection for the MSM and control the spread of sexually transmitted diseases.

关 键 词：男男性行为人群 人乳头瘤病毒 疫苗 

分 类 号：R186[医药卫生—流行病学]